Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection Pharmaceutical Investing
Sol-Gel Technologies Announces Collaborative Agreement for Generic Product with Perrigo Pharmaceutical Investing
Aerie Pharmaceuticals Reports Topline Result from Rhopressa Mechanism of Action Study Pharmaceutical Investing
Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer Biotech Investing
Oragenics Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine Safety Review Pharmaceutical Investing
